 Orgenesis Inc said its 2Q 2021 revenues rose from 1.75 million to 10.5 million compared to the same period in 2020. The international biotech company, which is focused on unlocking the full potential of cell and gene therapies CGTs in an affordable and accessible format, credited the Orgenesis Point of Care POCare Platform as a key factor to the profit boost. 